Octapharma Limited
Supplier — contracts won
£1.7bnTotal value£1,670,258,640 across every award on file
3Awardspublished since 4 July 2024
Who buys from them
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 2 | £1.7bn |
| Norfolk and Norwich University Hospitals NHS… | 1 | £72k |
Every award on file
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
| 1 Jan 2025 | Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B)East of England | Norfolk and Norwich University Hospitals NHS… | Octapharma Limited | £72k |
Organisations are grouped by name, because the notices carry no identifier that appears on all of them. A body that publishes under two spellings will appear twice; two different companies with the same trading name will appear as one. Check the individual notices before drawing a conclusion.